<?xml version="1.0" encoding="UTF-8"?>
<p>There are fewer marketed antibodies that target bacteria, and these target toxins, namely anthrax and 
 <italic>Clostridium</italic> cytotoxin [
 <xref rid="pntd.0007860.ref027" ref-type="bibr">27</xref>]. This paucity may be due to a lack of discovery efforts, a consequence of the historic availability of cheap and effective antibiotics. However, with the worrying rise of antibiotic resistance, the tide is turning [
 <xref rid="pntd.0007860.ref032" ref-type="bibr">32</xref>].
</p>
